Domenico Abelardo

Dr. Domenico Abelardo

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2024 in Clinical Kidney Journal
Verified
Journal Article
Open access
GDGraziella D'Arrigo
Graziella D'Arrigo
SESamar Abd ElHafeez
Samar Abd ElHafeez
SMSabrina Mezzatesta
Sabrina Mezzatesta
DADomenico Abelardo
Domenico Abelardo
FPFabio Pasquale Provenzano
Fabio Pasquale Provenzano
GTGiovanni Tripepi
Giovanni Tripepi
Biostatistics plays a pivotal role in developing, interpreting and drawing conclusions from clinical, biological and epidemiological data. However, the improper application of statistical methods can lead to erroneous conclusions and misinterpretations. This paper provides a comprehensive examination of the most frequent mistakes encountered in the biostatistical analysis process. We identified and elucidated 10 common errors in biostatistical analysis. These include using the wrong metric to describe data, misinterpreting P-values, misinterpreting the 95% confidence interval, misinterpreting the hazard ratio as an index of prognostic accuracy, ignoring the sample size calculation, misinterpreting analysis by strata in randomized clinical trials, confusing correlation and causation, misunderstanding confounders and mediators, inadequately codifying variables during the data collection, and bias arising when group membership is attributed on the basis of future exposure in retrospective studies. We discuss the implications of these errors and propose some practical strategies to mitigate their impact. By raising awareness of these pitfalls, this paper aims to enhance the rigor and reproducibility of biostatistical analyses, thereby fostering more robust and reliable biomedical research findings.

15 April 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
APAngelo Pascarella
Angelo Pascarella
LMLucia Manzo
Lucia Manzo
OMOreste Marsico
Oreste Marsico
EAEmilio Africa
Emilio Africa
ACAlessandra Coglitore
Alessandra Coglitore
EFEdoardo Ferlazzo
Edoardo Ferlazzo
Background/Objectives: Brain magnetic resonance imaging (MRI) often reveals acute peri-ictal abnormalities (PMAs) during or shortly after status epilepticus (SE) but also following single seizures (SiS) or clusters of seizures (CS). However, the incidence, characteristics, and progression remain not clearly known. This study aimed to investigate incidence, clinical correlations, and evolution of PMAs in SE, CS, and SiS patients. Methods: This prospective observational study enrolled patients with SE, CS, and SiS who underwent MRI within 120 h of the ictal event. Demographic, clinical, EEG, and MRI data were collected. Patients with PMAs (PMAs+) underwent serial follow-up MRI. Incidence, association with clinical characteristics, and progression of PMAs were analyzed across the three groups. Results: Among 76 patients (30 SE, 22 CS, 24 SiS), PMAs were observed in 31 (41%), with a significant difference between groups (p = 0.011), as PMAs were less frequent in SiS (17%) compared to SE (57%) and CS (45%) patients. Acute symptomatic SE/seizures were significantly more common in PMAs+ compared to PMAs− in the overall cohort (52% vs. 29%; p = 0.045) and in the SiS group (100% vs. 25%; p = 0.031). History of epilepsy was less frequent in PMAs+ in the whole cohort (13% vs. 40%; p = 0.011) and in SE in particular (12% vs. 46%, p = 0.049). No association between PMAs and seizure type, SE duration, etiology, time to MRI, and EEG findings (p > 0.005) was found. The temporal cortex and hippocampus were most frequently affected by PMAs. Follow-up MRI performed in 16 patients showed resolution of PMAs in 75% (5/7 SE, 3/6 CS, 3/3 SiS) within a median time of 24 days (IQR: 8–39). Conclusions: PMAs were more common in SE and CS than in SiS. Acute underlying pathology was frequently associated with PMAs. While duration of ictal activity is an important factor, it was not the sole determinant. Most PMAs resolved, particularly in SiS. Further studies are needed to clarify the pathophysiological mechanism and clinical implications of PMAs.

13 July 2024 in Epilepsy & Behavior
Verified
Journal Article
Open access
AMAnna Mammì
Anna Mammì
VBValentina Bova
Valentina Bova
IMIolanda Martino
Iolanda Martino
ISIlaria Sammarra
Ilaria Sammarra
EFEdoardo Ferlazzo
Edoardo Ferlazzo
SGSara Gasparini
Sara Gasparini
Functional seizures (FS) are brief, involuntary changes in behaviour or consciousness, distinct from epileptic seizures, potentially associated with psychological dissociation. Binge eating disorder (BED) was linked to psychological and somatic dissociation also. However, any connection between FS and BED is insufficiently explored. We aimed to assess BED prevalence in individuals with FS, anxiety/depression (AD), and healthy subjects (HS), to investigate dissociation's link to binge eating, and to explore psychological characteristics of FS individuals. Participants underwent evaluations based on ILAE guidelines and DSM-5 criteria, including questionnaires assessing binge eating, dissociation, anxiety, depression and personality traits. Inclusion criteria were age > 18 years, no history of substance abuse, no history of epilepsy, and no use of medications inducing eating disorders. We found significantly more frequent and severe binge-eating symptoms in individuals with FS and AD compared to HS. Depression and dissociation correlated with binge-eating symptoms in both AD and FS groups. The PID-5 facet 'Perseveration' predicted binge-eating attitudes only in FS individuals; they reported more childhood emotional neglect and increased disinhibition compared do AD people. This study underscores the commonality of binge-eating symptoms in FS individuals, emphasizing its association with dissociation symptoms. This finding support the hypothesis of a link between dissociation and eating disorders. Unique clinical characteristics in individuals with FS were identified, as a compulsive dimension related to binge-eating symptoms, providing a comprehensive understanding of their psychological profile and guiding targeted therapeutic interventions.

15 April 2025 in Epilepsy & Behavior
Verified
Journal Article
Open access
APAngelo Pascarella
Angelo Pascarella
LMLucia Manzo
Lucia Manzo
RCRoberta Cutellè
Roberta Cutellè
DTDenise Tedeschi
Denise Tedeschi
OMOreste Marsico
Oreste Marsico
EFEdoardo Ferlazzo
Edoardo Ferlazzo
Anti-seizure medications (ASMs) to prevent seizures after craniotomy are not currently recommended. This survey investigates practice patterns and decision-making strategies regarding post-craniotomy ASM prophylaxis among Italian neurosurgeons. An online cross-sectional survey was conducted (November 2022-March 2023). The survey link was distributed to neurosurgeons working in Italian Pediatric and Adult Neurosurgery Units. The survey consisted of ten multiple-choice questions covering ASM prescription for individuals without seizures and those experiencing early post-surgical seizures, including type and timing of ASMs, decision factors, and withdrawal management. Eighty-two neurosurgeons from 64/128 (50 %) Neurosurgery Units completed the questionnaire. Forty-two (52.1 %) neurosurgeons reported routinely prescribing ASMs post-craniotomy for seizure-free individuals. The surgical site, particularly supratentorial locations, emerged as a relevant factor influencing the decision. Levetiracetam (LEV) was the most prescribed ASM (41/42; 97.6 %), with 23.8 % of neurosurgeons maintaining it beyond six months. After early post-surgical seizures, almost all surgeons (96.3 %) prescribed ASMs, primarily LEV (77/79; 97.5 %). Only 4 (5.1 %) surgeons routinely discontinued ASMs within one month, while 32 (40.5 %) continued treatment beyond six months. Notably, only 39 (48.7 %) sought neurologist assistance for ASM management. This survey reveals widespread ASM use (especially LEV) after craniotomy in routine neurosurgery practice in Italy, even in cases where their indication is not supported by existing evidence. These findings emphasize the need to promote the widespread dissemination of standardized, evidence-based recommendations to better align clinical practices with scientific evidence, ultimately improving patient care.

13 August 2025 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Open access
DADomenico Abelardo
Domenico Abelardo
PRPasquale Raimondo
Pasquale Raimondo
CSCristina Santonocito
Cristina Santonocito
ABAlessio Barile
Alessio Barile
MDMauro D’AMora
Mauro D’AMora
GPGianluca Paternoster
Gianluca Paternoster
To evaluate the role of urinary liver-type fatty acid binding protein (L-FABP) in early detection of acute kidney injury (AKI) after endovascular aortic aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA). Prospective, observational, multicenter study. Four university hospitals from January 2024 to June 2024. Fifty-nine hospitalized patients with AAA. Patients undergoing EVAR were included. Demographic data, comorbidities, and renal function data were recorded at baseline and after intervention. L-FABP data were collected at baseline and at 6 hours and 24 hours after surgery. The cohort had a mean age of 70.2 ± 7.3 years and was predominantly male (84.7%). Positive L-FABP results were observed in 24.1% of patients at 6 hours post-EVAR and in 23.7% at 24 hours post-EVAR. A positive L-FABP status at both time points was significantly associated with elevated postoperative serum creatinine (SCr) and reduced estimated glomerular filtration rate (eGFR) (p ≤ 0.015), reduced urine output (p = 0.009 and p < 0.001), and shorter hospital length of stay (LOS) (p = 0.004 and p = 0.013). Multivariable logistic regression analysis fully confirmed these associations. Predictive models incorporating L-FABP achieved high accuracy for identifying patients with reduced diuresis (up to 86.1%). Additionally, L-FABP at 6 hours and 24 hours predicted LOS, whereas SCr and eGFR values did not. Urinary L-FABP is emerging as a sensitive biomarker for AKI in patients undergoing EVAR.

2 December 2024 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
MGMercedes Gori
Mercedes Gori
DADomenico Abelardo
Domenico Abelardo
APAnnalisa Pitino
Annalisa Pitino
ESEleni Stamellou
Eleni Stamellou
ABAdamantia Bratsiakou
Adamantia Bratsiakou
GDGraziella D'Arrigo
Graziella D'Arrigo